p.116 抽出テキスト

324. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266. PMID: 11904577 325. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982- 992. PMID: 19339088 326. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113: 1063-1070. PMID: 16490821 327. Best PJ, Berger PB, Davis BR, et al. PRESTO Investigators. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol 2004; 44: 1786-1791. PMID: 15519008 328. Charytan DM, Yang SS, McGurk S, et al. Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease. Nephrol Dial Transplant 2010; 25: 3654-3663. PMID: 20551089 329. Ashrith G, Lee VV, Elayda MA, et al. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Am J Cardiol 2010; 106: 348-353. PMID: 20643244 330. Charytan DM, Li S, Liu J, et al. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation 2012; 126 Suppl: S164-S169. PMID: 22965978 331. Reddan DN, Szczech LA, Tuttle RH, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 2003; 14: 2373- 2380. PMID: 12937316 332. Komiya T, Ueno G, Kadota K, et al. CREDO-Kyoto Investigators. An optimal strategy for coronary revascularization in patients with severe renal dysfunction. Eur J Cardiothorac Surg 2015; 48: 293-300. PMID: 25416698 333. Natsuaki M, Furukawa Y, Morimoto T, et al. Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization. Circ J 2011; 75: 1616-1625. PMID: 21532182 334. Ix JH, Mercado N, Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 2005; 149: 512-519. PMID: 15864241 335. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 Suppl: S16-S23. PMID: 11443763 336. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 2001; 12: 1516- 1523. PMID: 11423581 337. Hemmelgarn BR, Southern D, Culleton BF, et al. Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (AP- PROACH) Investigators. Survival after coronary revascularization among patients with kidney disease. Circulation 2004; 110: 1890- 1895. PMID: 15451786 338. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211. PMID: 12390949 339. Marui A, Kimura T, Nishiwaki N, et al. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 2014; 114: 555-561. PMID: 24996550 340. Ishii H, Toriyama T, Aoyama T, et al. Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients. Circ J 2012; 76: 1609-1615. PMID: 22484980 341. Otsuka Y, Ishiwata S, Inada T, et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry. Eur Heart J 2011; 32: 829-837. PMID: 21196442 342. Hirose H, Amano A, Takahashi A, et al. Coronary artery bypass grafting for patients with non-dialysis-dependent renal dysfunction (serum creatinine ≧2.0 mg/dl). Eur J Cardiothorac Surg 2001; 20: 565-572. PMID: 11509280 343. Ascione R, Nason G, Al-Ruzzeh S, et al. Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency. Ann Thorac Surg 2001; 72: 2020-2025. PMID: 11789787 344. Tashiro T, Nakamura K, Morishige N, et al. Off-pump coronary artery bypass grafting in patients with end-stage renal disease on hemodialysis. J Card Surg 2002; 17: 377-382. PMID: 12630533 345. Chukwuemeka A, Weisel A, Maganti M, et al. Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: a propensity score analysis. Ann Thorac Surg 2005; 80: 2148-2153. PMID: 16305860 346. Sajja LR, Mannam G, Chakravarthi RM, et al. Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufficiency: a randomized study. J Thorac Cardiovasc Surg 2007; 133: 378-388.e3. PMID: 17258568 347. Yu HY, Li JY, Sun S, et al. Late dialysis rate for coronary artery bypass grafting patients with moderate-to-severe renal impairment: comparison between off-pump and conventional method. Eur J Cardiothorac Surg 2008; 33: 364-369. PMID: 18249555 348. Kinoshita T, Asai T, Suzuki T. Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease. J Thorac Cardiovasc Surg 2015; 150: 315-321.e3. PMID: 26142149 349. Kai M, Okabayashi H, Hanyu M, et al. Long-term results of bilateral internal thoracic artery grafting in dialysis patients. Ann Thorac Surg 2007; 83: 1666-1671. PMID: 17462376 350. Kinoshita T, Tawa M, Suzuki T, et al. Endothelial dysfunction of internal thoracic artery graft in patients with chronic kidney disease. J Thorac Cardiovasc Surg 2017; 153: 317-324.e1. PMID: 27771030 351. Nakayama Y, Sakata R, Ura M. Bilateral internal thoracic artery use for dialysis patients: does it increase operative risk? Ann Thorac Surg 2001; 71: 783-787. PMID: 11269451 352. 日本循環器学会.循環器病の診断と治療に関するガイドライン(2011年度合同研究班報告):弁膜疾患の非薬物治療に関するガイ

ドライン(2012年改訂版).http://www.j-circ.or.jp/guideline/pdf/ JCS2012_ookita_h.pdf 353. Rapp AH, Hillis LD, Lange RA, et al. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol 2001; 87: 1216-1217. PMID: 11356405 354. Holmes DR, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. Ann Thorac Surg 2016; 101: 789-800. PMID: 27175453 355. Takimoto S, Saito N, Minakata K, et al. Favorable clinical outcomes of transcatheter aortic valve implantation in Japanese patients-- First report from the Post-Approval K-TAVI Registry. Circ J 2016; 81: 103-109. PMID: 27916776 356. Verheul HA, van den Brink RB, Bouma BJ, et al. Analysis of risk factors for excess mortality after aortic valve replacement. J Am Coll Cardiol 1995; 26: 1280-1286. PMID: 7594044 357. Fremes SE, Goldman BS, Ivanov J, et al. Valvular surgery in the elderly. Circulation 1989; 80: I77-I90. PMID: 2788532 358. Gautier M, Pepin M, Himbert D, et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 2011; 7: 549-555. PMID: 21930458 359. Masson JB, Lee M, Boone RH, et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 165-173. PMID: 20665855 360. Dewey TM, Brown DL, Herbert MA, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010; 89: 758-767. PMID: 20172123 361. Kotronias RA, Kwok CS, George S, et al. Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2017; 6: e005960. PMID: 28655733 362. Paradis JM, White JM, Généreux P, et al. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement. J Am Heart Assoc 2017; 6: e005070. PMID: 28219920 363. Chauhan D, Thawabi M, Haik N, et al. Impact of coronary artery disease on postoperative outcomes in patients undergoing transcatheter aortic valve replacement (TAVR): Is preoperative coronary revascularization necessary? J Invasive Cardiol 2016; 28: E179-E184. PMID: 27922809 364. Di Gioia G, Pellicano M, Toth GG, et al. Fractional flow reserve-guided revascularization in patients with aortic stenosis. Am J Cardiol 2016; 117: 1511-1515. PMID: 26976789 365. Stanojevic D, Gunasekaran P, Tadros P, et al. Intravenous adenosine infusion is safe and well tolerated during coronary fractional flow reserve assessment in elderly patients with severe aortic stenosis. J Invasive Cardiol 2016; 28: 357-361. PMID: 27315577 366. Yousefzai R, Bajaj N, Krishnaswamy A, et al. Outcomes of patients